Stockscreener 앱 받기
17.25
2.54%
-0.45
시간 외 거래:
17.25
전일 마감가:
$17.70
열려 있는:
$17.7
하루 거래량:
74,322
Relative Volume:
0.71
시가총액:
$221.70M
수익:
$16.96M
순이익/손실:
$-23.88M
주가수익비율:
-8.226
EPS:
-2.097
순현금흐름:
$-20.66M
1주 성능:
-0.12%
1개월 성능:
+4.04%
6개월 성능:
-11.90%
1년 성능:
+5.50%
1일 변동 폭
$17.13
$17.85
1주일 범위
$17.02
$18.13
52주 변동 폭
$14.90
$22.50
Mediwound Ltd Stock (MDWD) Company Profile
Compare MDWD vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
17.25 | 227.48M | 16.96M | -23.88M | -20.66M | -2.097 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2025-05-02 | 개시 | Alliance Global Partners | Buy |
| 2025-02-28 | 개시 | Craig Hallum | Buy |
| 2024-07-16 | 재확인 | Maxim Group | Buy |
| 2022-12-22 | 개시 | Maxim Group | Buy |
| 2022-07-18 | 재개 | Oppenheimer | Outperform |
| 2020-09-23 | 개시 | BTIG Research | Buy |
| 2016-11-28 | 개시 | Aegis Capital | Buy |
| 2016-08-17 | 개시 | Wells Fargo | Outperform |
| 2014-04-16 | 개시 | Oppenheimer | Outperform |
모두보기
Mediwound Ltd 주식(MDWD)의 최신 뉴스
Breakouts Watch: Will MediWound Ltd benefit from sector rotation2026 Support & Resistance & Reliable Momentum Entry Alerts - baoquankhu1.vn
MediWound Highlights U.S. Expert Consensus Supporting EscharEx® Strategy for Chronic Wound Debridement - Quiver Quantitative
MediWound highlights consensus supporting debridement strategy - Investing.com
U.S. wound experts favor less invasive care, aligning with MediWound - Stock Titan
Understanding Momentum Shifts in (MDWD) - Stock Traders Daily
Published on: 2026-04-11 10:40:16 - baoquankhu1.vn
Wound Care Biologics Market Is Going to Boom | MediWound Ltd. • Acelity L.P. Inc. • Smith & Nephew plc - openPR.com
MediWound Ltd. (M8W.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada
MediWound to Present New EscharEx® Data at Leading Wound Care Conferences - Sahm
MDWD SEC FilingsMediwound 10-K, 10-Q, 8-K Forms - Stock Titan
Mediwound Ltd. Presents New Escharex Data At Wound Care Conferences - marketscreener.com
From burns to ulcers: new MediWound EscharEx data heads to 3 meetings - Stock Titan
Why Vericel (VCEL) Is Up 11.8% After Landing Long-Term BARDA Deal For NexoBrid - simplywall.st
MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million - Sahm
MediWound Ltd. (NASDAQ:MDWD) Given Average Rating of "Hold" by Brokerages - MarketBeat
MediWound (MDWD) Gains as Vericel Secures $197M Contract for Nex - GuruFocus
MediWound Highlights Vericel’s $197 Million BARDA Contract for NexoBrid - TipRanks
BARDA’s up-to-$197M NexoBrid contract highlighted by MediWound (MDWD) - Stock Titan
MediWound and Vericel Secure Up to $197 Million BARDA Contract for NexoBrid® Procurement and Development - Quiver Quantitative
Aug Highlights: Is MediWound Ltd forming a bullish divergence2026 Sector Review & Technical Buy Zone Confirmations - baoquankhu1.vn
MediWound Sets May 6, 2026 Shareholder Meeting to Vote on Board, Auditor and CEO Bonus - The Globe and Mail
Avoiding Lag: Real-Time Signals in (MDWD) Movement - Stock Traders Daily
MediWound (NASDAQ: MDWD) plans 2026 AGM, director slate and CEO bonus - Stock Titan
Fed Meeting: Should value investors consider MediWound LtdSell Signal & Daily Profit Focused Stock Screening - baoquankhu1.vn
MediWound (MDWD) director details options, RSU and share holdings - stocktitan.net
MediWound Ltd. (NASDAQ:MDWD) Q4 2025 earnings call transcript - msn.com
Gap Down: Can MediWound Ltd keep up with sector leaders2026 Sector Review & Smart Swing Trading Alerts - baoquankhu1.vn
Pullback Watch: Does MediWound Ltd meet Warren Buffetts criteriaEarnings Overview Report & Weekly Consistent Profit Watchlists - baoquankhu1.vn
MediWound (NASDAQ:MDWD) Stock Passes Below 200-Day Moving AverageTime to Sell? - MarketBeat
Discipline and Rules-Based Execution in MDWD Response - Stock Traders Daily
Aug Drivers: Will MediWound Ltd outperform the market in YEARGap Down & Verified Short-Term Plans - baoquankhu1.vn
MediWound (MDWD) director Rubinstein reports options and share holdings - Stock Titan
[Form 3] MediWound Ltd. Initial Stateme... - Stock Titan
MediWound (MDWD) CMO details options and RSU awards in Form 3 filing - Stock Titan
MediWound Ltd. (MDWD) director discloses shares, RSUs and options stake - Stock Titan
MediWound (MDWD) VP reports stock options and RSU holdings in Form 3 - Stock Titan
MediWound (MDWD) EVP Meyer Yaron files Form 3 on equity holdings - Stock Titan
MediWound (MDWD) details director Stephen Wills’ initial share and option holdings - Stock Titan
MediWound (MDWD) COO Shmuel details option and RSU holdings in Form 3 - Stock Titan
MediWound (MDWD) CEO details warrants, RSUs and options in Form 3 - Stock Titan
MediWound (MDWD) director Nachum Shamir details shares, RSUs and options - Stock Titan
MediWound (MDWD) Stock Price, News & Analysis - MarketBeat
Medical Maggots Market Hits New High | Major Giants BioMonde, Maggot Therapy, MediWound - openPR.com
Menora Mivtachim Holdings LTD. Purchases 61,039 Shares of MediWound Ltd. $MDWD - MarketBeat
Rosalind Advisors Inc. Buys 341,993 Shares of MediWound Ltd. $MDWD - MarketBeat
Performance Recap: Is MediWound Ltd forming a bullish divergenceDip Buying & AI Optimized Trading Strategy Guides - baoquankhu1.vn
FY2030 Earnings Estimate for MediWound Issued By Maxim Group - Defense World
Institution Moves: Does MediWound Ltd meet Warren Buffetts criteria2026 Earnings Impact & Advanced Swing Trade Entry Plans - baoquankhu1.vn
FY2030 Earnings Forecast for MediWound Issued By Maxim Group - MarketBeat
MediWound Is the Biotech Governments Have Been Stockpiling for E - GuruFocus
MediWound Is the Biotech Governments Have Been Stockpiling for Exactly These Kinds of Wars (NASDAQ: MDWD) - TipRanks
Mediwound Ltd (MDWD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.69%
0.25%
자본화:
|
볼륨(24시간):